Medicine information ZEPOSIA 0.23mg / 0.46mg capsules
- Product code:
- W67064001
- Quantity:
- 1
- Indicated for:
- multiple sclerosis; ulcerative colitis
- Route of administration:
- oral
- Substance:
- ozanimod (S1P receptor modulator)
- ATC
- L04AE02 — Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Sphingosine-1-phosphate (S1P) receptor modulators
Ozanimod is a sphingosine-1-phosphate receptor modulator used in the treatment of relapsing multiple sclerosis and moderate to severe ulcerative colitis. It works by reducing lymphocyte migration into the central nervous system or intestinal mucosa, thereby decreasing inflammation.
The medication is administered orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular tests to monitor the therapy's effects.
Patients should be aware of potential side effects, such as headache, infections, or elevated liver enzymes. It is important to inform the doctor of any unusual symptoms.
Common side effects include headache, infections, and elevated liver enzymes. In rare cases, severe reactions such as bradycardia or macular edema may occur. Patients should be informed of these risks before use.
The medication is administered orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular tests to monitor the therapy's effects.
Patients should be aware of potential side effects, such as headache, infections, or elevated liver enzymes. It is important to inform the doctor of any unusual symptoms.
Common side effects include headache, infections, and elevated liver enzymes. In rare cases, severe reactions such as bradycardia or macular edema may occur. Patients should be informed of these risks before use.
General data about ZEPOSIA 0.23mg / 0.46mg
- Substance:
- ozanimod
- Date of latest medicines list:
- 01-10-2026
- Product code:
- W67064001
- Strength:
- 0.23mg / 0.46mg
- Pharmaceutical form:
- capsules
- Quantity:
- 1
- Product type:
- Original
- Price:
- 1632.44 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Strengths available for ozanimod
- 0.23mg/0.46mg
- 0.92mg
Official documents
The SmPC text is not displayed because a match to this medicine, strength and pharmaceutical form has not been confirmed.
The correspondence between the document and the displayed text is unconfirmed.
- Source institution
- EMA
- Document language
- English
- Source record: first published
- 27/05/2020
- Source record: last updated
- 03/03/2026
Reimbursement lists for ZEPOSIA 0.23mg / 0.46mg Bristol Myers Squibb
G31A (C1) - Chronic inflammatory bowel disease
- Price
- 1632.44 RON
- Copayment
- 1632.44 RON
- Patient payment
- 0.00 RON